With a focus on actionable insights and strategic value, The Business Research Company’s 2026 market reports include market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.
Artificial Intelligence (AI) In Clinical Trials Market Size Outlook: A $47.22 Billion Market By 2030, Growing At 35.3% Annually
The artificial intelligence (AI) in clinical trials market has experienced substantial growth recently and is forecast to expand from $10.11 billion in 2025 to $14.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 39.6%. This historical expansion is primarily due to several factors, including higher clinical trial failure rates, increased R&D investments by pharmaceutical companies, a surge in clinical data volumes, the imperative for faster drug approvals, and the inherent inefficiencies present in traditional trial processes.
The artificial intelligence (AI) in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $47.22 billion in 2030 at a compound annual growth rate (CAGR) of 35.3%. This expansion during the forecast period can be attributed to the rise of decentralized clinical trials, increasing regulatory acceptance of AI tools, the growth of precision medicine research, a demand for more cost-efficient trials, and advancements in healthcare analytics. Major trends anticipated in this period include AI-based trial design optimization, predictive patient enrollment modeling, data-driven site selection, automated clinical outcome analysis, and adaptive trial execution platforms.
Make Data-Driven Decisions With A Free Artificial Intelligence (AI) In Clinical Trials Market Sample Report:
Key Demand Driver Expected To Lift Artificial Intelligence (AI) In Clinical Trials Market Revenue
The increasing requirement to manage expenses associated with clinical trials is anticipated to drive the expansion of artificial intelligence in the clinical trial market. Clinical trials, which are research investigations designed to evaluate medical, surgical, or behavioral interventions in individuals, inherently incur significant costs, encompassing both research activities and patient care. Given the expensive nature of drug development and related clinical trial procedures, artificial intelligence is employed to facilitate superior drug discovery, more effectively designed and safer trials, and improved patient results at lower expenditures. For example, in February 2023, information from Genetic Engineering and Biotechnology News revealed that the expense of developing a new drug among the top 20 global biopharma companies escalated by 15%, moving from $298 million in 2022 to approximately $2.3 billion in 2023, a figure that includes costs incurred during clinical trial development. Furthermore, a January 2023 report from the National Bureau of Economic Research (NBER) suggested that integrating AI over the next five years is projected to yield substantial healthcare cost reductions, ranging from 5 to 10% of healthcare spending, which translates to roughly $200 billion to $360 billion in yearly savings. Consequently, the growing necessity to reduce clinical trial expenditures will fuel the adoption of artificial intelligence in the clinical trial market.
Exploring The Artificial Intelligence (AI) In Clinical Trials Market Through Its Key Segments
The artificial intelligence (AI) in clinical trials market covered in this report is segmented –
1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Application: Oncology, Neurological Disease And Condition, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology Disease, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Company, Contract Research Organizations, Other End-Users
Subsegments:
1) By Software: AI-driven Analytics Platforms, Data Management Tools, Patient Recruitment Solutions, Predictive Modeling Software
2) By Services: Consulting Services, Data Annotation And Labeling Services, Custom AI Model Development, Implementation And Integration Services
New Trends Redefining Competition In The Artificial Intelligence (AI) In Clinical Trials Market
Leading companies operating within the artificial intelligence in clinical trials market are prioritizing the development of innovative technologies, such as AI feasibility and recruitment platforms. These platforms are systems or tools that leverage artificial intelligence (AI) to assess the viability and potential success of clinical trials, while also aiding in the efficient recruitment of suitable participants. For instance, in June 2023, a US-based research provider company, announced the launch of ‘ObjectiveScreen’. This AI-powered feasibility and recruitment platform is designed to enhance clinical trial performance and results by improving patient identification, prequalification, and retention processes. ObjectiveScreen facilitates direct connectivity between clinical trial sites and patients’ electronic health records (EHRs). The AI platform further promotes patient engagement by simplifying and streamlining appointment scheduling and communication processes.
Artificial Intelligence (AI) In Clinical Trials Market Competition: Key Players And Industry Participants
Major companies operating in the artificial intelligence (AI) in clinical trials market are Medable Inc.; PathAI inc.; Saama Technologies Inc.; TriNetX LLC; SymphonyAI Summit Inc.; Aktana; Nference Inc.; Insilico Medicine Inc.; Vineti Inc.; Innoplexus AG; Healx; AiCure Inc.; MEDIAN Technologies SA; Owkin Inc.; Science 37; Ardigen SA; Cyft Inc.; Unlearn.AI Inc.; Mendel AI; Deep Lens Inc.; Antidote Technologies Inc.; Arterys Inc.; Euretos BV; Halo Health Systems Inc.; Trials.AI Inc.; Transparency Life Sciences; BioAge Labs Inc.; Wave Life Sciences Ltd.; BioSymetrics Inc.
Get The Detailed Artificial Intelligence (AI) In Clinical Trials Market Research Report Here:
Artificial Intelligence (AI) In Clinical Trials Market Regional Overview: Largest Market And Global Coverage
North America was the largest region in the artificial intelligence (AI) in clinical trials market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
